Literature DB >> 14736902

Influence of antiarrhythmia therapy on survival times of 19 clinically healthy Doberman pinschers with dilated cardiomyopathy that experienced syncope, ventricular tachycardia, and sudden death (1985-1998).

Clay A Calvert1, John Brown.   

Abstract

Overtly healthy Doberman pinschers, having moderate to severe myocardial failure secondary to dilated cardiomyopathy, which experienced ventricular tachycardia, syncope or collapse, and sudden death were studied to determine the effect of antiarrhythmic medication on their clinical outcome. Antiarrhythmia drug therapy may have retarded sudden death in 13 treated dogs compared to the six dogs not administered antiarrhythmia drugs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14736902     DOI: 10.5326/0400024

Source DB:  PubMed          Journal:  J Am Anim Hosp Assoc        ISSN: 0587-2871            Impact factor:   1.023


  4 in total

1.  A locus on chromosome 5 is associated with dilated cardiomyopathy in Doberman Pinschers.

Authors:  Theresa-Bernadette Mausberg; Gerhard Wess; Julia Simak; Lisa Keller; Michaela Drögemüller; Cord Drögemüller; Matthew T Webster; Hannah Stephenson; Joanna Dukes-McEwan; Tosso Leeb
Journal:  PLoS One       Date:  2011-05-20       Impact factor: 3.240

2.  Predictors of Sudden Cardiac Death in Doberman Pinschers with Dilated Cardiomyopathy.

Authors:  L Klüser; P J Holler; J Simak; G Tater; P Smets; D Rügamer; H Küchenhoff; G Wess
Journal:  J Vet Intern Med       Date:  2016-05       Impact factor: 3.333

3.  Detection and comparison of microRNA expression in the serum of Doberman Pinschers with dilated cardiomyopathy and healthy controls.

Authors:  Carola Steudemann; Stefan Bauersachs; Karin Weber; Gerhard Wess
Journal:  BMC Vet Res       Date:  2013-01-17       Impact factor: 2.741

4.  Sphericity index and E-point-to-septal-separation (EPSS) to diagnose dilated cardiomyopathy in Doberman Pinschers.

Authors:  P J Holler; G Wess
Journal:  J Vet Intern Med       Date:  2013-11-13       Impact factor: 3.333

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.